Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

1. WO2012005876 - COMPOSITIONS ET PROCÉDÉS DE STIMULATION DE MAGP-1 POUR AMÉLIORER L'ASPECT DE LA PEAU

Numéro de publication WO/2012/005876
Date de publication 12.01.2012
N° de la demande internationale PCT/US2011/040157
Date du dépôt international 13.06.2011
CIB
C12N 5/00 2006.01
CCHIMIE; MÉTALLURGIE
12BIOCHIMIE; BIÈRE; SPIRITUEUX; VIN; VINAIGRE; MICROBIOLOGIE; ENZYMOLOGIE; TECHNIQUES DE MUTATION OU DE GÉNÉTIQUE
NMICRO-ORGANISMES OU ENZYMES; COMPOSITIONS LES CONTENANT; CULTURE OU CONSERVATION DE MICRO-ORGANISMES; TECHNIQUES DE MUTATION OU DE GÉNÉTIQUE; MILIEUX DE CULTURE
5Cellules non différenciées humaines, animales ou végétales, p.ex. lignées cellulaires; Tissus; Leur culture ou conservation; Milieux de culture à cet effet
CPC
A61K 2800/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
2800Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
20Chemical, physico-chemical or functional or structural properties of the composition as a whole
A61K 31/5377
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
53751,4-Oxazines, e.g. morpholine
5377not condensed and containing further heterocyclic rings, e.g. timolol
A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
A61K 36/39
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
39Convolvulaceae (Morning-glory family), e.g. bindweed
A61K 36/53
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
A61K 36/74
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
74Rubiaceae (Madder family)
Déposants
  • AVON PRODUCTS, INC. [US/US]; c/o Joan M. McGillycuddyi 1345 Avenue of the Americas New York, New York 10105-0196, US (AllExceptUS)
  • ZHENG, Qian [CN/US]; US (UsOnly)
  • CHEN, Siming W. [US/US]; US (UsOnly)
  • SANTHANAM, Uma [US/US]; US (UsOnly)
  • LYGA, John W. [US/US]; US (UsOnly)
Inventeurs
  • ZHENG, Qian; US
  • CHEN, Siming W.; US
  • SANTHANAM, Uma; US
  • LYGA, John W.; US
Mandataires
  • ZELLER, Charles J.; Avon Products, Inc. Avon Place Suffern, New York 10901, US
Données relatives à la priorité
61/360,08330.06.2010US
Langue de publication anglais (EN)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) COMPOSITIONS AND METHODS FOR STIMULATING MAGP-1 TO IMPROVE THE APPEARANCE OF SKIN
(FR) COMPOSITIONS ET PROCÉDÉS DE STIMULATION DE MAGP-1 POUR AMÉLIORER L'ASPECT DE LA PEAU
Abrégé
(EN)
The present disclosure relates to methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, by application of one or a combination of natural compounds or extracts that stimulate MAGP-1 expression and which improves the appearance of aged and/or photodamaged skin. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof in an amount effective to improve the condition and aesthetic appearance of skin.
(FR)
La présente invention concerne des procédés permettant de traiter, prévenir et améliorer l'état et l'aspect esthétique de la peau, en particulier de traiter, prévenir, améliorer, réduire et/ou éliminer les ridules et/ou les rides de la peau, par application d'un composé ou extrait naturel qui stimule l'expression de MAGP-1, ou d'une combinaison de ceux-ci, ce qui améliore l'aspect de la peau vieillie et/ou abimée par le soleil. Les compositions de l'invention s'appliquent par voie topique sur la peau, ou sont administrées par des moyens directs sur le site en ayant besoin en quantité efficace pour améliorer l'état et l'aspect esthétique de la peau.
Dernières données bibliographiques dont dispose le Bureau international